thiamphenicol glycinate acetylcysteinate

**Thiamphenicol glycinate acetylcysteinate** is a fixed small-molecule antibacterial and mucolytic product comprising thiamphenicol glycinate and N-acetylcysteine. Following administration, it provides thiamphenicol-mediated inhibition of bacterial protein synthesis through the bacterial 50S ribosomal subunit, while acetylcysteine reduces mucus viscosity by disrupting disulfide bonds in airway mucus glycoproteins. It has been marketed by Zambon as Fluimucil products for respiratory tract infections, including upper-airway infections, acute bronchitis, chronic bronchitis, and exacerbations of chronic obstructive pulmonary disease, with intramuscular, inhaled, and oral product presentations reported. ([journals.sagepub.com](https://journals.sagepub.com/doi/pdf/10.1177/039463200702000319))

Brand names

FluimucilFluimucil AntibioticFluimucil AntibioticoFluimucil-Antibiotic IT

Other names

N-acetyl-L-cysteine, compound with thiamphenicol glycinateTGAthiamphenicol glycinate acetylcysteinethiamphenicol glycinate acetylcisteinatethiamphenicol glycinate N-acetylcysteinate